RE: AGM ? .........k3Thanks for clearing that up for me K3........however I do believe Endicrinologists would tend to disagree with your view......considering the TypeI trial is hitting efficacy endpoints well beyond anything ever before seen in a human trial of this nature and without this even being a dosing targeted study.